Posts made in February, 2019


NOVA Health Recovery Ketamine Infusion Center | 703-844-0184 – call for a Ketamine infusion or Ketamine nasal spray to treat your depression Alexandria, Va 22306 EMAIL is email@novahealthrecovery.com   NEW VARIATION OF KETAMINE TO BE APPROVED BY FDA FOR TREATMENT OF DEPRESSION “The biggest breakthrough in depression treatment since Prozac” 6 FEBRUARY 2019 Back in July of 2017, the world’s first ketamine...

Read More

Ketamine Could Be the Key to Reversing America’s Rising Suicide Rate NOVA Health Recovery : Call 703-844-0184 if you are interested in Ketamine Therapy for depression | Alexandria, Va 22306 | 22101 | We offer Esketamine and intranasal Ketamine therapy for PTSD, depression, anxiety and others.   NOVA Health Recovery Alexandria, Virginia << Link to Ketamine Treatment Center email@novahealthrecovery.com   Ketamine Could...

Read More

    Depression Therapy With Party-Drug Roots Faces FDA Panel Review   NOVA Health Recovery : Call 703-844-0184 if you are interested in Ketamine Therapy for depression | Alexandria, Va 22306 | 22101 | We offer Esketamine and intranasal Ketamine therapy for PTSD, depression, anxiety and others.     Potential for abuse and strategies for containing any risks from an experimental depression treatment from Johnson...

Read More

NOVA Health Recovery << Link   Call for Ketamine Infusion evaluation at 703-844-0184 or email at email@novahealthrecovery.com. Ketamine in nasal form and IV formulations for mood, depression, PTSD, pain, and numerous conditions.   Ketamine Is Showing Early Success With Treating OCD Tonic Video By the time she signed up for an experimental ketamine study, one young mother’s obsessive compulsive disorder had forced her...

Read More

    Call NOVA Health Recovery | 703-844-0184 for a consultation to receive Ketamine for your pain or mood disorder. Alexandria, Va 22306 or click here: NOVA Health recovery     BDNF-VEGF interplay key to rapid antidepressant actions A study in Biological Psychiatry investigates the mechanisms of fast-acting antidepressants   E-MAIL Philadelphia, January 31, 2019 — A study by researchers at Yale University...

Read More